Drug
Lipofundin
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph phase_4
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(1)
Other(2)
Detailed Status
unknown2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
terminated133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_4
Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
NCT04277923
terminatedphase_4
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
NCT02633384
unknownphase_4
Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
NCT01683162
Clinical Trials (3)
Showing 3 of 3 trials
NCT04277923Phase 4
Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
NCT02633384Phase 4
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
NCT01683162Phase 4
Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3